Immunogenicity and Tolerability of Booster Typhoid Conjugate Vaccine (TCV) 5-6 Years After Initial Dose in Children in Burkina Faso | MicrobiomeTrials← Back to trialsNCT07624175
Immunogenicity and Tolerability of Booster Typhoid Conjugate Vaccine (TCV) 5-6 Years After Initial Dose in Children in Burkina Faso
CompletedPHASE2INTERVENTIONAL
Trial Details
Start: 2024-08-17Est. Completion: 2024-10-26
Enrollment target: 147 participants Locations- Schiphra Protestant Hospital, Ouagadougou, Burkina Faso
Other microbiome trials you might be interested in
Catatonia
Catatonia is a severe form of psychomotor disturbance with a heterogenous presentation. It affects approximately 10% of …
Lille, FranceEst. completion Jan 2027
Malaria Vaccines
The aim of this study is to identify an optimal infant vaccine schedule for a malaria vaccine which is better aligned wi…
Bobo-Dioulasso, Burkina FasoEst. completion Sep 27, 2027